Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
Glioblastoma multiforme (GBM) is a grade IV astrocytoma and the most common form of malignant brain tumor in adults. GBM remains one of the most fatal and least successfully treated solid tumors: current therapies provide a median survival of 12-15 months after diagnosis, due to the high recurrence...
Main Authors: | Chiara Cilibrasi, Gabriele Riva, Gabriele Romano, Massimiliano Cadamuro, Riccardo Bazzoni, Valentina Butta, Laura Paoletta, Leda Dalprà, Mario Strazzabosco, Marialuisa Lavitrano, Roberto Giovannoni, Angela Bentivegna |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5231344?pdf=render |
Similar Items
-
In vitro anticancer drug test: A new method emerges from the model of glioma stem cells
by: Gabriele Riva, et al.
Published: (2014-01-01) -
Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
by: Chiara Cilibrasi, et al.
Published: (2016-01-01) -
Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
by: Simona Baronchelli, et al.
Published: (2013-01-01) -
DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?
by: Angela Bentivegna, et al.
Published: (2013-01-01) -
The Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles
by: Angela Bentivegna, et al.
Published: (2016-01-01)